Equity Overview
Price & Market Data
Price: $3.83
Daily Change: -$0.26 / 6.79%
Daily Range: $3.76 - $4.34
Market Cap: $17,230,056
Daily Volume: 725,684
Performance Metrics
1 Week: 0.05%
1 Month: 261.5%
3 Months: 197.1%
6 Months: 49.69%
1 Year: -78.07%
YTD: 224.8%
Company Details
Employees: 57
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.